Following a successful start for the first cohort, applications are now open for the Aspiring to Excellence programme in 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.
Whilst COVID19 is impacting on us all, NASS is keen to keep driving forward as much as possible and being practical with Aspiring to Excellence, and we welcome applications. The deadline for rheumatology teams to apply is 24 July 2020 and all the application details can be found on the NASS website.…
Read more of this article
In light of the current COVID-19 situation, the Institute of Osteopathy is providing information for all osteopaths, based on the most current UK Government advice.
People with fibromyalgia are finding themselves wondering whether they are more at risk of getting Coronavirus, as are other chronically ill and healthy people. The lack of clarity over the origin of our condition does not help in these circumstances. The government uses broad categories to inform people and control risk to vulnerable people. But these broad categories are collecting people and inflaming their anxiety, which does not help their chronic condition.
Free CPD Webinar: Virtual Consultations with Mike James
Many people with rheumatoid arthritis (RA) and their families will be concerned about how the Coronavirus (COVID-19) affects them. NRAS has provided a summary of all the important information that you need to know about Coronavirus and rheumatoid arthritis, including:
When people are scared they do one of two things – reach out for support and support others, or look after number one. We’ve seen lots of examples of both recently. ARMA members have chosen the first approach. They’ve been sharing information, working together to solve some common problems such as how to advise healthcare professionals working in private practice.
NICE has produced new, rapid guidelines on the active management of COVID-19 infection, which are likely to include patients with rheumatoid arthritis. NICE is also reviewing guidance on ibuprofen and other non-steroidal anti-inflammatory drugs in relation to impact on Covid-19 illness. Please see this page: 
Chronic (persistent or long-lasting or recurrent) pain significantly impacts individuals, their families and carers. For people with pain, the day-to-day concerns of living with and managing pain are of the highest importance, more so than the underlying condition. Here are some resources on pain available to people at home.